4//SEC Filing
Baeuerle Patrick 4
Accession 0001209191-19-062169
CIK 0001708493other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 5:32 PM ET
Size
9.7 KB
Accession
0001209191-19-062169
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Sale
Common Stock
2019-12-27$15.81/sh−75,562$1,194,922→ 273,953 total(indirect: See footnote) - Sale
Common Stock
2019-12-27$18.07/sh−1,400$25,297→ 262,136 total(indirect: See footnote) - Sale
Common Stock
2019-12-27$16.90/sh−10,417$176,062→ 263,536 total(indirect: See footnote)
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $15.51 to $16.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Shares indirectly held by APAK Solutions GmbH, of which the Reporting Person has sole voting and investment power over these shares.
- [F4]Represents the weighted average sales price per share. The shares sold at prices ranging from $16.51 to $17.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F5]Represents the weighted average sales price per share. The shares sold at prices ranging from $17.57 to $18.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001362054
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 5:32 PM ET
- Size
- 9.7 KB